Analyst Reco. Amplifon S.p.A.

Stocks

AMP

IT0004056880

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana Other stock markets 16:45:00 11/06/2026 BST			5-day change	1st Jan Change
10.48 ^EUR	-0.52%		-0.99%	-23.78%

06-09	Buy-side pressure on MIB; Unipol and BPER lead gains	AN
06-08	Clínica Baviera, the copy-paste machine

Analyst Reco.

05-25	Kepler Cheuvreux Upgrades Amplifon to Buy, Boosts PT	MT
05-13	Amplifon Price Target Rises as Bernstein Ups Estimates Post Q1 Results; Market-perform Rating Kept	MT
05-06	Morningstar Downgrades Amplifon to Hold, Lifts PT	MT
05-05	Amplifon: Promising start to 2026
04-02	BNP Paribas Downgrades Amplifon to Neutral, Cuts PT	MT
03-26	Amplifon: Hardship persists
03-18	Jefferies Downgrades Amplifon to Hold Rating, Cuts PT	MT
03-18	Barclays Downgrades Amplifon to Equalweight, Cuts PT	MT
03-17	Equita SIM Downgrades Amplifon to Hold Rating, Cuts PT	MT
03-16	Amplifon shares tumble following external growth operation
03-16	Amplifon: Amplifon is hunting big game
03-05	Amplifon: Q4 miss rattles market's faith in delivering on next year's targets
02-11	Morningstar Kicks Off Amplifon Coverage with Hold Rating	MT
12-08	AlphaValue/Baader Europe Cuts Amplifon Price Target, Estimates Amid Ongoing Macro Headwinds	MT
12-05	Amplifon target cut amid market slowdown
11-19	RBC Capital Starts Amplifon Coverage with Sector Perform Rating	MT
11-19	RBC Initiates Amplifon at Sector Perform, Notes 'Balanced' Risk-Reward Amid Market Weakness	MT
30/10/25	Banca Akros Downgrades Amplifon to Neutral, Cuts PT	MT
30/10/25	Amplifon: Q3 in the rearview, positive signals for the future
20/08/25	Intesa Sanpaolo Downgrades Amplifon to Neutral, Cuts PT	MT
30/07/25	Amplifon: Unjustified market reaction to Q2 miss and guidance downgrade
15/05/25	Amplifon: Taking into account short-term challenges
07/05/25	Amplifon: Despite Q1 miss, markets appreciated the profitability improvements and maintained guidance
07/03/25	Intesa Sanpaolo Upgrades Amplifon to Buy, Lowers PT	MT
07/03/25	Amplifon: Q4 miss and weaker-than-expected 2025 guidance panicked markets